reports
Parker Reports Fiscal 2025 Third Quarter Results
Parker Reports Fiscal 2025 Third Quarter Results Record margins, EPS and YTD cash flow from operations CLEVELAND, May 01, 2025 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today reported results for the quarter ended March 31, 2025, that included the following highlights (compared with the prior year quarter): Fiscal 2025 Third Quarter Highlights: Sales were $5.0 billion; organic sales growth was 1%Net income was $961 million, an increase of 32%, or $904 million adjusted, an increase of 6%EPS were $7.37, an increase ...
Nexxen Announces April 2025 Share Repurchase Program Summary
Nexxen Announces April 2025 Share Repurchase Program Summary NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced that during April 2025 the Company repurchased 1,877,280 Ordinary Shares at an average price of $8.74. In April 2025, Nexxen completed its previous $50 million Ordinary Share repurchase program and launched a new and ongoing $50 million Ordinary Share repurchase program, which is expected to continue until ...
Intellia Therapeutics to Hold Conference Call to Discuss First Quarter...
Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2025 Earnings and Company Updates CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, will present its first quarter 2025 financial results and operational highlights in a conference call on May 8, 2025, at 8 a.m. ET. To join the call: U.S. callers should dial 1-833-316-0545 and international callers should dial 1-412-317-5726, approximately five minutes before the c...
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 1...
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025 SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2025 financial and operating results after the market close on Monday, May 12, 2025, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET. To participate in the conference call by telephone, dial (800) 343-4849 or (203) 518-9848 and reference Maravai LifeSciences, Conference I...
United Community Banks, Inc. Announces Completion of Merger With ANB ...
United Community Banks, Inc. Announces Completion of Merger With ANB Holdings, Inc., The Parent of American National Bank GREENVILLE, S.C., May 01, 2025 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) (“United”) completed its merger with ANB Holdings, Inc. (“ANB”) effective May 1, 2025. In this transaction, ANB’s wholly-owned bank subsidiary, American National Bank (“ANB Bank”), was also merged into United’s bank subsidiary, United Community Bank (“United Community”). ANB Bank will operate under the United Community brand after all core systems, signage, and branding are con...
Laureate Education Reports Financial Results For the First Quarter Of ...
Laureate Education Reports Financial Results For the First Quarter Of 2025 Company Updates Full-Year 2025 Guidance Following Completion of Favorable Enrollment Intake Cycle MIAMI, May 01, 2025 (GLOBE NEWSWIRE) -- Laureate Education, Inc. (NASDAQ: LAUR), which operates five higher education institutions across Mexico and Peru, today announced financial results for the first quarter and three months ended March 31, 2025. First Quarter 2025 Highlights (compared to first quarter 2024): New enrollments decreased 2%, up 7% adjusted for the timing of semester start dates.Total enrollments in...
Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANA...
Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia Study ANAVEX3-71-SZ-001 successfully completes enrollment with a total of 71 participants Both Part A (16 participants) and Part B (55 participants) of the placebo-controlled Phase 2 study fully enrolled Top line data expected in the second half of 2025 NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's d...
Digi Power X Maintains Strong Cash and Crypto Position with Debt-Free ...
Digi Power X Maintains Strong Cash and Crypto Position with Debt-Free Operations and Reports April 2025 Production Results MIAMI, May 01, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), a vertically integrated power infrastructure company focused on developing cutting-edge data centers for high-performance computing, is pleased to provide unaudited production results for the month ended April 30, 2025, combined with an operations update. All monetary references are expressed in USD unless otherwise indicated. Monthly Production Hig...
AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on tr...
AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) reports on its year end 2024 and In the year ended December 31, 2024 revenue increased by 37% year over year to $4,785,711 and gross profit increased by 56% to $1,880,306.In the three months ended December 31, 2024 revenue increased by 5% year over year to $1,421,076 and gross profit increased by 18% to $589,930. “Launching and expanding HealthTab™ in North East ...
Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program...
Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC As SVP, Neuroscience, Dr. Bordey will lead Cassava’s ongoing research and development efforts Dr. Bordey to direct the scientific evaluation of simufilam in TSC-related epilepsy, and potentially additional pipeline indications AUSTIN, Texas, May 01, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a clinical-stage biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders, today announced that Angélique Borde...
SIGA to Host Business Update Call on May 8, 2025 Following Release of ...
SIGA to Host Business Update Call on May 8, 2025 Following Release of First-Quarter 2025 Results NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, May 8, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relatio...
Prelude Therapeutics to Participate in Citizens Life Sciences Conferen...
Prelude Therapeutics to Participate in Citizens Life Sciences Conference WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens Life Sciences Conference taking place in New York on May 7, 2025. On Wednesday, May 7, 2025, at 11:00 a.m. ET, Kris Vaddi, Ph.D., Chief Executive Officer of Prelude, Jane Huang, M.D., President and Chief Medical Officer, and Peggy Scherle, Ph.D., Chief Scientific Officer will participate in a fireside chat. A live webcast of the ...
Notice of Knight Therapeutics' First Quarter 2025 Results Conference C...
Notice of Knight Therapeutics' First Quarter 2025 Results Conference Call MONTREAL, May 01, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, will release its first quarter 2025 financial results on Thursday, May 8, 2025 prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call. Date: Thursday, May 8, 2025 Time: 8:30 a.m. ET Telephone: Toll Free: 1-888-699-1199 or International 1-416-945-...
Avis de conférence téléphonique de Thérapeutique Knight sur ses résult...
Avis de conférence téléphonique de Thérapeutique Knight sur ses résultats du premier trimestre 2025 MONTRÉAL, 01 mai 2025 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight »), société pharmaceutique spécialisée panaméricaine (ex. EU), publiera ses résultats financiers du premier trimestre 2025, ce jeudi 8 mai 2025 avant l’ouverture du marché. À la suite de cette publication, Knight sera l’hôte d’une conférence téléphonique et d’une webémission. Knight invite cordialement toutes les parties intéressées à participer à cet appel. Date : Jeudi 8 mai 2025 Heure : 8 h 30 HE ...
Altimmune to Present at Upcoming EASL International Liver Congress™ 20...
Altimmune to Present at Upcoming EASL International Liver Congress™ 2025 GAITHERSBURG, Md., May 01, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing next-generation peptide-based therapeutics for liver and cardiometabolic diseases, today announced that the Company will present analyses of pemvidutide-treated subjects with metabolic dysfunction-associated steatotic liver disease (MASLD) utilizing the MASH Resolution Index (MASHResInd; Loomba 2024), a highly sensitive non-invasive measure of MASH histologic response, in a poster session at ...
Gain Therapeutics to Participate at The Citizens Life Sciences Confere...
Gain Therapeutics to Participate at The Citizens Life Sciences Conference BETHESDA, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that Gene Mack, President and CEO of Gain, will present and participate in one-on-one meetings at The Citizens Life Sciences Conference, being held May 7th-8th in New York City, NY. Details of the presentation are as follows: Date: Thursday, May 8,...
Portillo’s Celebrates Italian Beef Day Throughout May with Free Sandwi...
Portillo’s Celebrates Italian Beef Day Throughout May with Free Sandwiches, Citywide Surprises and a Meaty Makeover with the Chicago Transit Authority Guests can enjoy a month-long party in honor of Italian Beef Day – including a BOGO sandwich deal, a takeover of the CTA’s Blue Line and a multi-city scavenger hunt – fans of the legendary sandwich are in for a flavorful ride CHICAGO, May 01, 2025 (GLOBE NEWSWIRE) -- This May, Portillo’s – the famed and fast-growing purveyor of unrivaled Chicago-style street food – is celebrating its most iconic sandwich, the Italian Beef, in a big way. I...
Pineapple Financial Launches Pineapple+, Slashes $1M in Costs, Strengt...
Toronto, Ontario--(Newsfile Corp. - May 1, 2025) - Pineapple Financial Inc. (NYSE American: PAPL) ("Pineapple" or the "Company"), a leading Canadian mortgage technology and brokerage firm, today announced what it believes is a transformational milestone, official launch of Pineapple+, its fully proprietary, end-to-end broker platform that is expected to eliminate nearly $1 million in annual third-party technology, development and licensing costs while advancing the Company's strategy to streamline operations, accelerate revenue growth, and achieve sustained profitability.We believe that, Pine...
Nationz Technologies Inc: 2 directors
Two Directors at Nationz Technologies Inc sold 2,149,800 shares at between 24.590CNY and 24.670CNY. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directo...
WISeKey Confirms June Launch of Next-Generation WISeSat Satellite with...
WISeKey Confirms June Launch of Next-Generation WISeSat Satellite with SpaceX Featuring Encrypted Communications and SEALCOIN Integration WISeKey Confirms June Launch of Next-Generation WISeSat Satellite with SpaceX Featuring Encrypted Communications and SEALCOIN Integration Geneva, Switzerland, May 1, 2025 –WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, blockchain, and IoT company, today announces the upcoming launch of its next-generation WISeSat.Space satellite aboard a SpaceX mission in June 2025. This milestone marks a major ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.